bioAffinity Technologies, Inc. (BIAF)

NASDAQ: BIAF · Real-Time Price · USD

1.040

+0.010 (0.97%)

At close: Mar 6, 2026, 4:00 PM EST

1.012

-0.028 (-2.72%)

After-hours: Mar 6, 2026, 7:12 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Diagnostic R&D	8.65K	19.44K	-
Diagnostic R&D Growth	-55.49%	-	-
Laboratory Services	9.35M	2.51M	4.80K
Laboratory Services Growth	272.19%	52222.65%	-
Total	9.36M	2.53M	4.80K
Total Growth	269.68%	52627.44%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	9.36M	2.53M	4.80K
United States Growth	269.68%	52627.44%	-
Total	9.36M	2.53M	4.80K
Total Growth	269.68%	52627.44%	-

Source: S&P Global Market Intelligence.